These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy. Ishii S, Inomata T, Fujita T, Iida Y, Ikeda Y, Nabeta T, Yanagisawa T, Naruke T, Mizutani T, Koitabashi T, Takeuchi I, Ako J. Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939 [Abstract] [Full Text] [Related]
7. Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study. Nabeta T, Inomata T, Fujita T, Iida Y, Ikeda Y, Sato T, Ishii S, Maekawa E, Mizutani T, Naruke T, Koitabashi T, Inoue Y, Ako J. J Cardiol; 2017 Aug; 70(2):185-191. PubMed ID: 27979675 [Abstract] [Full Text] [Related]
8. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC. Circ Res; 2013 Jan 04; 112(1):165-73. PubMed ID: 23065358 [Abstract] [Full Text] [Related]
11. Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy. Xu Y, Li W, Wan K, Liang Y, Jiang X, Wang J, Mui D, Li Y, Tang S, Guo J, Guo X, Liu X, Sun J, Zhang Q, Han Y, Chen Y. Circ Heart Fail; 2021 Jan 04; 14(1):e007944. PubMed ID: 33185117 [Abstract] [Full Text] [Related]
12. Association of myocardial fibrosis, B-type natriuretic peptide, and cardiac magnetic resonance parameters of remodeling in chronic ischemic cardiomyopathy. Henkel DM, Glockner J, Miller WL. Am J Cardiol; 2012 Feb 01; 109(3):390-4. PubMed ID: 22078219 [Abstract] [Full Text] [Related]
15. Ventricular reverse remodeling early after mitral valve repair for severe chronic mitral regurgitation with atrial fibrillation. Song BG, On YK, Jeon ES, Park JH, Choi JO, Lee SC, Park SW, Kim JS, Park PW. Cardiology; 2009 Feb 01; 114(2):132-41. PubMed ID: 19521078 [Abstract] [Full Text] [Related]
18. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL. Am J Cardiol; 2011 Apr 01; 107(7):1065-70. PubMed ID: 21296328 [Abstract] [Full Text] [Related]
20. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy. Sarli B, Topsakal R, Kaya EG, Akpek M, Lam YY, Kaya MG. J Investig Med; 2013 Apr 01; 61(4):728-32. PubMed ID: 23429699 [Abstract] [Full Text] [Related] Page: [Next] [New Search]